Trade Summary

2 days ago, Kihara James, serving as PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 5,401 shares at $21.18 per share, for a total transaction value of $114,393.18. Following this transaction, Kihara James now holds 24,509 shares of ACAD.

This sale represents a 18.06% decrease in Kihara James's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 6:00 PM ET, 1 day after the trade was made.

ACADIA PHARMACEUTICALS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.